Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accumulated Expenses (2016 - 2025)

CV Sciences' Accumulated Expenses history spans 12 years, with the latest figure at $522000.0 for Q4 2024.

  • For Q4 2024, Accumulated Expenses changed 0.0% year-over-year to $522000.0; the TTM value through Dec 2024 reached $522000.0, changed 0.0%, while the annual FY2024 figure was $522000.0, 0.0% changed from the prior year.
  • Accumulated Expenses for Q4 2024 was $522000.0 at CV Sciences, roughly flat from $522000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $10.9 million in Q4 2021 and bottomed at $500000.0 in Q1 2023.
  • The 5-year median for Accumulated Expenses is $938000.0 (2023), against an average of $3.9 million.
  • The largest annual shift saw Accumulated Expenses tumbled 92.21% in 2023 before it surged 170.8% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $9.8 million in 2020, then increased by 11.32% to $10.9 million in 2021, then crashed by 38.62% to $6.7 million in 2022, then crashed by 92.21% to $522000.0 in 2023, then changed by 0.0% to $522000.0 in 2024.
  • Per Business Quant, the three most recent readings for CVSI's Accumulated Expenses are $522000.0 (Q4 2024), $522000.0 (Q3 2024), and $1.4 million (Q1 2024).